Inventor · disambiguated record
Henry H. Flanner
Also filed as: FLANNER HENRY · FLANNER HENRY H
25 granted patents·15 pending applications·701 citations·filing 1997–2023
96Inventor score
Files withSUPERNUS PHARMACEUTICALS INC11SHIRE LAB INC8BURNSIDE BETH A7FLANNER HENRY H5GLYCOMIMETICS INC3
Top patents by PatentIndex Score
40 records- 0197US6361796B1Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2000·Granted Mar 26, 2002·87 cites·21 claims
- 0297US6284276B1Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2000·Granted Sep 4, 2001·106 cites·26 claims
- 0396US6814979B2Osmotic drug delivery systemSHIRE LAB INC·Filed 2002·Granted Nov 9, 2004·61 cites·15 claims
- 0495US6384020B1Rapid immediate release oral dosage formSHIRE LAB INC·Filed 2000·Granted May 7, 2002·131 cites·12 claims
- 0594US7763635B2Once daily dosage forms of trospiumSUPERMUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 27, 2010·20 cites·6 claims
- 0694US6514532B2Soluble form osmotic dose delivery systemSHIRE LAB INC·Filed 2001·Granted Feb 4, 2003·43 cites·15 claims
- 0793US7781448B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·6 cites·44 claims
- 0893US7759359B2Method of treating bladder dysfunction with once-a-day trospium salt formulationSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Jul 20, 2010·6 cites·9 claims
- 0993US6110498AOsmotic drug delivery systemSHIRE LAB INC·Filed 1997·Granted Aug 29, 2000·118 cites·28 claims
- 1092US7410978B2Once daily dosage forms of trospiumSUPERNUS PHARMACEUTICALS INC·Filed 2004·Granted Aug 12, 2008·22 cites·37 claims
- 1190US7781449B2Trospium chloride treatment methodSUPERNUS PHARMACEUTICALS INC·Filed 2007·Granted Aug 24, 2010·8 cites·26 claims
- 1289US6838093B2System for osmotic delivery of pharmaceutically active agentsSHIRE LAB INC·Filed 2001·Granted Jan 4, 2005·54 cites·20 claims
- 1385US11707474B2Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2019·Granted Jul 25, 2023·3 cites·57 claims
- 1478US8357394B2Compositions and methods for improved efficacy of penicillin-type antibioticsShionogi Inc·Filed 2006·Granted Jan 22, 2013·3 cites·7 claims
- 1571US8460710B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Jun 11, 2013·3 cites·37 claims
- 1670US8062672B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Nov 22, 2011·2 cites·42 claims
- 1770US2013089607A1Once daily trospium chloride treatment methodSUPERNUS PHARMACEUTICALS INC·Filed 2012·Application pending·0 cites
- 1868US2023414641A1Methods for treating acute myeloid leukemia and related conditionsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 1966US6793934B1Solid oral dosage formSHIRE LAB INC·Filed 1999·Granted Sep 21, 2004·27 cites·26 claims
- 2065US8299052B2Pharmaceutical compositions and methods for improved bacterial eradicationFLANNER HENRY H·Filed 2007·Granted Oct 30, 2012·1 cites·10 claims
- 2165US2010221354A1Pharmaceutical composition for once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2265US2010221355A1Pharmaceutical composition for once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2365US2010221356A1Pharmaceutical composition for once a day administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2465US2010222375A1Pharmaceutical Composition Comprising Trospium Chloride for Once-A-Day AdministrationSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2559US2010221352A1Pharmaceutical composition for the once-a-day oral administration of trospium chlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2659US2010221353A1Pharmaceutical Composition For Once-A-Day Administration of Trospium ChlorideSUPERNUS PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
- 2757US2008139526A1Modified release dosage forms of amoxicillinTREACY DONALD·Filed 2006·Application pending·0 cites
- 2856US9144548B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2011·Granted Sep 29, 2015·0 cites·19 claims
- 2955US8425936B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Apr 23, 2013·0 cites·17 claims
- 3055US8313775B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Nov 20, 2012·0 cites·16 claims
- 3155US8246996B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Aug 21, 2012·0 cites·34 claims
- 3254US2005142187A1Enhanced absorption of modified release dosage formsFiled 2004·Application pending·0 cites
- 3353US2010120896A1Once-A-Day RNA-Polymerase inhibiting and elongation factor G (EF-G) inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by methicillin-resistant staphylococcus aureusSANDER SANNA·Filed 2009·Application pending·0 cites
- 3452US2010016333A1Once-a-day (RNA-Polymerase Inhibiting or phenazine) - dihydropteroate synthase inhibiting - dihydrofolate reductase inhibiting antibiotic pharmaceutical product, formulation thereof, and use thereof in treating infection caused by Methicillin-Resistant Staphylococcus aureusFLANNER HENRY H·Filed 2007·Application pending·0 cites
- 3551US2004028729A1Pharmaceutical formulations with improved bioavailabilityFiled 2003·Application pending·0 cites
- 3650US9125803B2Gastric release pulse system for drug deliveryFLANNER HENRY H·Filed 2006·Granted Sep 8, 2015·0 cites·9 claims
- 3749US8778924B2Modified release amoxicillin productsFLANNER HENRY H·Filed 2006·Granted Jul 15, 2014·0 cites·60 claims
- 3846US8313776B2Antibiotic product, use and formulation thereofBURNSIDE BETH A·Filed 2004·Granted Nov 20, 2012·0 cites·16 claims
- 3938US2006222705A1Pharmaceutical tablet and apparatus and method for makingFLANNER HENRY H·Filed 2006·Application pending·0 cites
- 4038US2022289784A1Process for preparing an e-selectin inhibitor intermediateGLYCOMIMETICS INC·Filed 2020·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →